| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |